210 related articles for article (PubMed ID: 31511858)
41. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Millán BS; Navarro C
Hum Genet; 2009 Apr; 125(3):335. PubMed ID: 19309779
[No Abstract] [Full Text] [Related]
42. Fatigue and associated factors in 172 patients with McArdle disease: An international web-based survey.
Slipsager A; Andersen LK; Voermans NC; Lucia A; Karazi W; Santalla A; Vissing J; Løkken N
Neuromuscul Disord; 2024 Jan; 34():19-26. PubMed ID: 38042739
[TBL] [Abstract][Full Text] [Related]
43. Gene symbol: PYGM. Disease: McArdle disease.
Viétez I; Teijeira S; San Millán B; Navarro C
Hum Genet; 2008 Oct; 124(3):307. PubMed ID: 18846641
[No Abstract] [Full Text] [Related]
44. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Garcia-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA
Hum Genet; 2009 Apr; 125(3):342. PubMed ID: 19320015
[No Abstract] [Full Text] [Related]
45. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; San Millán B; Navarro C
Hum Genet; 2009 Apr; 125(3):349. PubMed ID: 19320035
[No Abstract] [Full Text] [Related]
46. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Millán BS; Navarro C
Hum Genet; 2009 Apr; 125(3):343. PubMed ID: 19320018
[No Abstract] [Full Text] [Related]
47. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Millán BS; Navarro C
Hum Genet; 2009 Apr; 125(3):339. PubMed ID: 19309786
[No Abstract] [Full Text] [Related]
48. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
[TBL] [Abstract][Full Text] [Related]
49. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
Bruno C; Cassandrini D; Martinuzzi A; Toscano A; Moggio M; Morandi L; Servidei S; Mongini T; Angelini C; Musumeci O; Comi GP; Lamperti C; Filosto M; Zara F; Minetti C
Hum Mutat; 2006 Jul; 27(7):718. PubMed ID: 16786513
[TBL] [Abstract][Full Text] [Related]
50. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay.
Sohn EH; Kim HS; Lee AY; Fukuda T; Sugie H; Kim DS
Neuromuscul Disord; 2008 Nov; 18(11):886-9. PubMed ID: 18667317
[TBL] [Abstract][Full Text] [Related]
51. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Otolano S; Parente P; San Millán B; Navarro C
Hum Genet; 2009 Apr; 125(3):352. PubMed ID: 19320040
[No Abstract] [Full Text] [Related]
52. Phenotype and genotype of 197 British patients with McArdle disease: An observational single-centre study.
Pizzamiglio C; Mahroo OA; Khan KN; Patasin M; Quinlivan R
J Inherit Metab Dis; 2021 Nov; 44(6):1409-1418. PubMed ID: 34534370
[TBL] [Abstract][Full Text] [Related]
53. A new mutation in PYGM causing McArdle disease in a Brazilian patient.
Gomes CP; da Silva AMS; Zanoteli E; Pesquero JB
Acta Neurol Belg; 2020 Jun; 120(3):705-707. PubMed ID: 31175620
[No Abstract] [Full Text] [Related]
54. Muscle glycogen unavailability and fat oxidation rate during exercise: Insights from McArdle disease.
Rodriguez-Lopez C; Santalla A; Valenzuela PL; Real-Martínez A; Villarreal-Salazar M; Rodriguez-Gomez I; Pinós T; Ara I; Lucia A
J Physiol; 2023 Feb; 601(3):551-566. PubMed ID: 36370371
[TBL] [Abstract][Full Text] [Related]
55. Differential glucose metabolism in mice and humans affected by McArdle disease.
Krag TO; Pinós T; Nielsen TL; Duran J; García-Rocha M; Andreu AL; Vissing J
Am J Physiol Regul Integr Comp Physiol; 2016 Aug; 311(2):R307-14. PubMed ID: 27280431
[TBL] [Abstract][Full Text] [Related]
56. Expression of glycogen phosphorylase isoforms in cultured muscle from patients with McArdle's disease carrying the p.R771PfsX33 PYGM mutation.
Nogales-Gadea G; Mormeneo E; García-Consuegra I; Rubio JC; Orozco A; Arenas J; Martín MA; Lucia A; Gómez-Foix AM; Martí R; Andreu AL
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957198
[TBL] [Abstract][Full Text] [Related]
57. Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis.
Satoh A; Hirashio S; Arima T; Yamada Y; Irifuku T; Ishibashi H; Motoda A; Sueda Y; Masaki T
CEN Case Rep; 2019 Aug; 8(3):194-199. PubMed ID: 30900170
[TBL] [Abstract][Full Text] [Related]
58. Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies.
Villarreal-Salazar M; Brull A; Nogales-Gadea G; Andreu AL; Martín MA; Arenas J; Santalla A; Lucia A; Vissing J; Krag TO; Pinós T
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052414
[TBL] [Abstract][Full Text] [Related]
59. Creation of an iPSC-Based Skeletal Muscle Model of McArdle Disease Harbouring the Mutation c.2392T>C (p.Trp798Arg) in the
Cerrada V; García-Consuegra I; Arenas J; Gallardo ME
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760875
[TBL] [Abstract][Full Text] [Related]
60. Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis.
García-Consuegra I; Asensio-Peña S; Garrido-Moraga R; Pinós T; Domínguez-González C; Santalla A; Nogales-Gadea G; Serrano-Lorenzo P; Andreu AL; Arenas J; Zugaza JL; Lucia A; Martín MA
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
